Literature DB >> 27579127

The Obstetric Medicine Listserv: review of controversies surrounding thrombophilia testing.

Michael P Carson1, H Keels S Jorn2.   

Abstract

A woman with no significant personal or family history of thrombosis asked her internist to obtain a thrombophilia work-up prior to starting the combined oral contraceptive for dysmenorrhoea, after another physician advised her to have the test. The case was sent to an international email discussion group where the consensus was that testing should not be done. The responses of the group and review of this controversial topic are presented.

Entities:  

Keywords:  factor V Leiden; oral contraceptives; thrombophilia

Year:  2012        PMID: 27579127      PMCID: PMC4989684          DOI: 10.1258/om.2011.110083

Source DB:  PubMed          Journal:  Obstet Med        ISSN: 1753-495X


  16 in total

Review 1.  Oral contraceptives and the risk of venous thrombosis.

Authors:  J P Vandenbroucke; J Rosing; K W Bloemenkamp; S Middeldorp; F M Helmerhorst; B N Bouma; F R Rosendaal
Journal:  N Engl J Med       Date:  2001-05-17       Impact factor: 91.245

2.  The truth about inherited thrombophilias and pregnancy.

Authors:  D Ware Branch
Journal:  Obstet Gynecol       Date:  2010-01       Impact factor: 7.661

3.  Factor V Leiden mutation and pregnancy-related complications.

Authors:  Ulla Kjellberg; Marianne van Rooijen; Katarina Bremme; Margareta Hellgren
Journal:  Am J Obstet Gynecol       Date:  2010-11       Impact factor: 8.661

4.  The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.

Authors:  V De Stefano; I Martinelli; P M Mannucci; K Paciaroni; P Chiusolo; I Casorelli; E Rossi; G Leone
Journal:  N Engl J Med       Date:  1999-09-09       Impact factor: 91.245

Review 5.  Factor V Leiden: should we screen oral contraceptive users and pregnant women?

Authors:  J P Vandenbroucke; F J van der Meer; F M Helmerhorst; F R Rosendaal
Journal:  BMJ       Date:  1996-11-02

6.  Bleeding complications in oral anticoagulant therapy. An analysis of risk factors.

Authors:  F J van der Meer; F R Rosendaal; J P Vandenbroucke; E Briët
Journal:  Arch Intern Med       Date:  1993-07-12

7.  Absence of association of thrombophilia polymorphisms with intrauterine growth restriction.

Authors:  Claire Infante-Rivard; Georges-Etienne Rivard; Wagner V Yotov; Emmanuelle Génin; Marguerite Guiguet; Clarice Weinberg; Robert Gauthier; Juan Carlos Feoli-Fonseca
Journal:  N Engl J Med       Date:  2002-07-04       Impact factor: 91.245

8.  The risk of venous and arterial thrombosis in hyperhomocysteinaemia is low and mainly depends on concomitant thrombophilic defects.

Authors:  Willem M Lijfering; Michiel Coppens; Marlène H W van de Poel; Saskia Middeldorp; Karly Hamulyák; Ivan Bank; Nic J G M Veeger; Martin H Prins; Harry R Büller; Jan van der Meer
Journal:  Thromb Haemost       Date:  2007-08       Impact factor: 5.249

9.  Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study.

Authors:  T Koster; F R Rosendaal; H de Ronde; E Briët; J P Vandenbroucke; R M Bertina
Journal:  Lancet       Date:  1993 Dec 18-25       Impact factor: 79.321

10.  Hereditary thrombophilia.

Authors:  Salwa Khan; Joseph D Dickerman
Journal:  Thromb J       Date:  2006-09-12
View more
  1 in total

1.  The OB Medicine Discussion listserv.

Authors:  Michael P Carson; Stephen E Lapinsky
Journal:  Obstet Med       Date:  2018-09-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.